Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination

Gaurav Batra, Deepika Rathna Murugesan, Souvick Chattopadhyay, Farha Mehdi, Ayushi, Mudita Gosain, Savita Singh, Soon Jyoti Das, Suprit Deshpande, Jayanta Bhattacharya, Anil K Pandey, Sankalp Jha, Shweta Goswami, Asim Das, Tanima Dwivedi, Nandini Sharma, Suresh Kumar, Pragya Sharma, Seema Kapoor, Pallavi Kshetrapal, Nitya Wadhwa, Ramachandran Thiruvengadam, Rakesh Kumar, Ritu Gupta, Pramod Kumar Garg, Shinjini Bhatnagar, DBT Consortium for COVID-19 Research
doi: https://doi.org/10.1101/2022.02.23.22271381
Gaurav Batra
1Translational Health Science and Technology Institute, Faridabad, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepika Rathna Murugesan
1Translational Health Science and Technology Institute, Faridabad, India
MDS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Souvick Chattopadhyay
1Translational Health Science and Technology Institute, Faridabad, India
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farha Mehdi
1Translational Health Science and Technology Institute, Faridabad, India
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayushi
1Translational Health Science and Technology Institute, Faridabad, India
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mudita Gosain
1Translational Health Science and Technology Institute, Faridabad, India
DHHM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Savita Singh
1Translational Health Science and Technology Institute, Faridabad, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soon Jyoti Das
1Translational Health Science and Technology Institute, Faridabad, India
Msc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suprit Deshpande
1Translational Health Science and Technology Institute, Faridabad, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jayanta Bhattacharya
1Translational Health Science and Technology Institute, Faridabad, India
3IAVI - HIV Vaccine Translational Research Laboratory, THSTI, Faridabad, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil K Pandey
5ESIC Medical College and Hospital, Faridabad, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sankalp Jha
5ESIC Medical College and Hospital, Faridabad, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shweta Goswami
5ESIC Medical College and Hospital, Faridabad, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asim Das
5ESIC Medical College and Hospital, Faridabad, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanima Dwivedi
2All India Institute of Medical Science, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nandini Sharma
4Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suresh Kumar
4Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pragya Sharma
4Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seema Kapoor
4Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pallavi Kshetrapal
1Translational Health Science and Technology Institute, Faridabad, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nitya Wadhwa
1Translational Health Science and Technology Institute, Faridabad, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramachandran Thiruvengadam
1Translational Health Science and Technology Institute, Faridabad, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakesh Kumar
2All India Institute of Medical Science, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ritu Gupta
2All India Institute of Medical Science, New Delhi, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pramod Kumar Garg
1Translational Health Science and Technology Institute, Faridabad, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pgarg@thsti.res.in shinjini.bhatnagar@thsti.res.in
Shinjini Bhatnagar
1Translational Health Science and Technology Institute, Faridabad, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pgarg@thsti.res.in shinjini.bhatnagar@thsti.res.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Both vaccination and natural infection lead to immunity and may augment mutual immune response against SARS-CoV-2. There is a need for an evidence-driven booster vaccination policy depending on durability of immune response.

Objective To determine the durability of humoral immune response with varying age, vaccine type, duration, and previous natural infection at least six months after complete vaccination with ChAdOx1 nCov-19 or BBV152.

Design Cross-sectional observational study conducted between November 2021 and January 2022.

Setting Participants were drawn from a DBT COVID-19 Research Consortium cohort in Delhi National Capital Region, India.

Participants We included 2003 individuals who had completed six months after complete vaccination: (i) vaccination with ChAdOx1 nCoV-19 and aged 18-59 years, (ii) vaccination with ChAdOx1 nCoV-19 and aged ≥60 years (iii) vaccination with BBV152 and aged 18-59 years (iv) vaccination with BBV152 and aged ≥60 years (v) vaccination with either vaccine plus SARS-CoV-2 infection referred as those having hybrid immunity. A group of 94 unvaccinated individuals was also included for comparison.

Exposure Age, vaccination type, prior SARS-CoV-2 infection and duration from vaccination/infection.

Main Outcome(s) and Measure(s) Humoral immune response determined by anti-RBD IgG concentrations and the presence of anti-nucleocapsid IgG.

Results The serum anti-RBD IgG antibodies were detected (cut-off 24 BAU/ml) in 85% participants with a median titer of 163 (IQR 73, 403) BAU/ml. In the hybrid immunity group, 97.6% [295 (IQR 128, 687) BAU/mL] tested positive for anti-RBD IgG compared to 81.3% [139 (IQR 62, 326) BAU/ml] of only vaccinated participants [χ2 test: p <0.001]. The median anti-RBD IgG titers were higher in the ChAdOx1 nCoV-19 versus BBV152 groups. The median anti-RBD IgG titer in the anti-nucleocapsid positive participants [326 (IQR 132, 739) BAU/ml] was significantly higher than in those without anti-nucleocapsid antibodies [131 (IQR 58, 288) BAU/ml; p <0.001]. The IgG anti-RBD antibodies was present in 85% of participants beyond a median of 8 months after complete vaccination.

Conclusions and Relevance Considering the wide seropositivity rates due to natural SARS-CoV-2 infection, recommendation for boosters should take into account past infections in the population.

Question What is the extent of waning of humoral immune response in various groups of vaccinated individuals at least six months after complete vaccination with ChAdOx1 nCov-19 or BBV152 with or without prior natural infection?

Findings Cross-sectional observational study demonstrates persistence of anti-RBD IgG in 85% of participants even beyond a median of 8 months after complete vaccination. The antibody concentrations were significantly higher in those with hybrid immunity.

Meaning Humoral immunity may last longer due to heterologous antigenic exposure following vaccination and natural infection emphasizing the need for contextualizing the booster policy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was supported by Ind-CEPI grant (102/IFD/SAN/5477/2018-2019) to Translational Health Science and Technology Institute, Faridabad; COVID-19 Bioresource grant (BT/PR40401/BIOBANK/03/2020); SARS-CoV-2 diagnostics development grant (Grant No. BT/PR40333/COD/139/11/2020) to Translational Health Science and Technology Institute, Faridabad by the Department of Biotechnology and; GIISER South Asia grant from Bill and Melinda Gates Foundation, Seattle, USA.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of Translational Health Science and Technology Institute, Faridabad; All India Institute of Medical Science, New Delhi; Maulana Azad Medical College and Lok Nayak Hospital, New Delhi and; ESIC Medical College and Hospital, Faridabad have given ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The deidentified dataset and related codes for analysis may be available to researchers upon request addressed to the corresponding author after publication after the approval of the Department of Biotechnology, Government of India.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 24, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination
Gaurav Batra, Deepika Rathna Murugesan, Souvick Chattopadhyay, Farha Mehdi, Ayushi, Mudita Gosain, Savita Singh, Soon Jyoti Das, Suprit Deshpande, Jayanta Bhattacharya, Anil K Pandey, Sankalp Jha, Shweta Goswami, Asim Das, Tanima Dwivedi, Nandini Sharma, Suresh Kumar, Pragya Sharma, Seema Kapoor, Pallavi Kshetrapal, Nitya Wadhwa, Ramachandran Thiruvengadam, Rakesh Kumar, Ritu Gupta, Pramod Kumar Garg, Shinjini Bhatnagar, DBT Consortium for COVID-19 Research
medRxiv 2022.02.23.22271381; doi: https://doi.org/10.1101/2022.02.23.22271381
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination
Gaurav Batra, Deepika Rathna Murugesan, Souvick Chattopadhyay, Farha Mehdi, Ayushi, Mudita Gosain, Savita Singh, Soon Jyoti Das, Suprit Deshpande, Jayanta Bhattacharya, Anil K Pandey, Sankalp Jha, Shweta Goswami, Asim Das, Tanima Dwivedi, Nandini Sharma, Suresh Kumar, Pragya Sharma, Seema Kapoor, Pallavi Kshetrapal, Nitya Wadhwa, Ramachandran Thiruvengadam, Rakesh Kumar, Ritu Gupta, Pramod Kumar Garg, Shinjini Bhatnagar, DBT Consortium for COVID-19 Research
medRxiv 2022.02.23.22271381; doi: https://doi.org/10.1101/2022.02.23.22271381

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1746)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (651)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2930)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (741)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12495)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (319)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2626)
  • Public and Global Health (5336)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)